(Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, ...

New research from the University of Dundee shows potential breakthrough for hard to treat cancers. Experts from the ...

Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotech developing RNA ...

Silexion Therapeutics Corp. ("Silexion" or the "Company"), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced significant new findings from ...

Altamira’s Senior Management will hold an investor call today, Tuesday, September 24, 2024, at 8:30 a.m. EDT its business update and first half 2024 results. Founder, Chairman, and CEO Thomas Meyer ...

Good morning, and welcome to the Altamira Therapeutics First Half 2024 and Business Update Conference Call. On today's call are Thomas Meyer, Altamira's Founder, Chairman and Chief Executive Officer; ...

Gig roles are emerging in India's corporate sector, with IT, pharmaceuticals, and energy firms hiring senior executives on ...

Silexion Therapeutics sees surge in trading volume after revealing new findings from a Phase 2 trial of LODER in pancreatic ...

Underscores Edible Garden’s commitment to sustainability in both agriculture as well as corporate cultureBELVIDERE, NJ, Sept.

The Real Brokerage Inc. , a technology platform reshaping real estate for agents, home buyers and sellers, today announced that the RealD2D Team, led by top producing agent and coach Duane Richins has ...

It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...

Controversial plans for a new shopping and food pavilion at Thomas Heatherwick’s Coals Drops Yard destination at Kings Cross ...